RIKEN, equivalent to CNRS in France, is a national research and development agency based in Japan and is the largest comprehensive research institution in the country. After RIKEN symposium held in Belgium on February 14 where Dr Nathalie Maubon, our CEO, and Dr Meryl Roudaut, our stem cell and liver Read more…
During this time of celebrating the Chinese New Year, HCS Pharma extends its best wishes to all those observing this special occasion. This year, the transition to the Year of the Dragon promises to bring strength, courage, and growth opportunities. We take this opportunity to thank our partners, clients, and Read more…
This is the end of Rania‘s 6-month internship in HCS Pharma about a new liver biochip system. After a first publication “Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix” in collaboration with the University of Technology of Compiègne (UTC) using the BIOMIMESYS® Liver hydroscaffold™ and HepG2/C3A (hepatocellular Read more…
It is a pleasure to announce that HCS Pharma has a new collaborative project dealing with Inflammasome et ion channels Team of OncoLille (PHYCELL Lab, INSERM U1003) in the frame of colon cancer, thanks to France Relance plan and Region Hauts-de-France. This project has started in October 2022 for 2 Read more…
We have the pleasure to introduce to you Michelle Haddad, our new CIFRE PhD student, who will work with us and PETALES laboratory (Procédés Et Transformations Alimentaires et Effets sur la Santé, Transformations & Agroressources, ULR 7519, UniLasalle Beauvais) to develop an in vitro intestinal model including microbiota actors. We Read more…
Launched in 2016, the adventure is coming to an end after 5 years of work carried out within the RHU CHOPIN (CHOlesterol Personalized INnovation), and with a strong collaboration between HCS Pharma and l’Institut du thorax. This collaborative project of national scope was led by Professor Bertrand Cariou, director of Read more…
Last week we were glad to attend the kick-off meeting of MIMLIVEROnChip, funded by the french National Agency for Research (ANR). It was held in UTC Compiègne, and the project is coordinated by Pr Cecile Legallais (BIOMÉCANIQUE ET BIOINGÉNIERIE (BMBI Laboratory) – UMR CNRS 7338). This project aims at developing Read more…
During ELRIGfr event in Rennes, We had the opportunity to present our work on genotoxicity assay (comet assay on TK6 & gH2AX on keratinocytes and HepG2) in collaboration with the team of in vitro of Galderma R&D. It is really exciting to work with them since they are really experts Read more…